Ignite Creation Date:
2024-05-06 @ 8:29 AM
Last Modification Date:
2024-10-26 @ 12:01 PM
Study NCT ID:
NCT02750189
Status:
COMPLETED
Last Update Posted:
2017-07-21
First Post:
2016-03-28
Brief Title:
The Economic Burden of Chronic Obstructive Pulmonary DiseaseCOPD in South Korea
Sponsor:
Konkuk University Medical Center
Organization:
Konkuk University Medical Center
Study Overview
Official Title:
The Economic Burden of Patients With COPD in South Korea
Status:
COMPLETED
Status Verified Date:
2017-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
BOC
Brief Summary:
The purpose of this study is to estimate a directindirect medical cost and to provide evidence establishing efficient strategies to reduce medical costs of COPD in Korea
Detailed Description:
This study is a multi-center research on economic burdens of COPD for a year It is composed of three phases detailed as follow
Phase 1 Direct Cost Estimation in COPD patients N 400 Direct cost determined as amount of money expended to medical institutes for treatment Estimated costs based on the information from Health insurance review agencyHIRA and The National Health and Nutrition Examination Survey NHANES data are collected
Phase 2 Indirect cost Estimation by Sampling Survey in COPD patient Indirect cost is extra-expanses excluding hospital fees including cost for transportation medical instruments home care services and loss of labor capacity reduction The information was collected by structured questionnaire for 12 weeks
Phase 3 DirectIndirect cost is validated and analyzed based on the collected information from phase 1 and 2 according to severity defined by the GOLD guideline
Phase 1 Direct Cost Estimation in COPD patients N 400 Direct cost determined as amount of money expended to medical institutes for treatment Estimated costs based on the information from Health insurance review agencyHIRA and The National Health and Nutrition Examination Survey NHANES data are collected
Phase 2 Indirect cost Estimation by Sampling Survey in COPD patient Indirect cost is extra-expanses excluding hospital fees including cost for transportation medical instruments home care services and loss of labor capacity reduction The information was collected by structured questionnaire for 12 weeks
Phase 3 DirectIndirect cost is validated and analyzed based on the collected information from phase 1 and 2 according to severity defined by the GOLD guideline
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None